Filing Details
- Accession Number:
- 0001203311-11-000099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-21 20:49:35
- Reporting Period:
- 2011-09-20
- Filing Date:
- 2011-09-21
- Accepted Time:
- 2011-09-21 20:49:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-09-20 | 5,600 | $6.34 | 1,050,655 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-09-20 | 5,600 | $20.00 | 1,045,055 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-09-21 | 24,400 | $6.34 | 1,069,455 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-09-21 | 24,400 | $20.15 | 1,045,055 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-09-20 | 5,600 | $6.34 | 5,600 | $6.34 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-09-21 | 24,400 | $6.34 | 24,400 | $6.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 84,400 | 2012-02-01 | No | 4 | M | Direct | |
| 60,000 | 2012-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 85,000 | Indirect | by Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Siegall on December 15, 2010 and described in a Form 8-K filed on December 17, 2010.
- 20.0012 represents an average price per share for the shares sold on 9/20/2011. The sell price for shares sold on this day ranged from $20.00 to 20.0211.
- 20.1521 represents an average price per share for the shares sold on 9/21/2011. The sell price for shares sold on this day ranged from $20.00 to 20.522.
- Amount of securities beneficially owned following reported transactions includes 78,137 Restricted Stock Units subject to vesting.
- Shares shall vest at a rate of 25% on 2/1/03 and monthly thereafter until all the shares are fully vested on 2/1/06.
Billionaire Hedge Funds
